Login / Signup

Nucleoside-modified AdoMet analogues for differential methyltransferase targeting.

Nicolas V CornelissenFreideriki MichailidouFabian MuttachKristina RauAndrea Rentmeister
Published in: Chemical communications (Cambridge, England) (2020)
Methyltransferases (MTases) modify a wide range of biomolecules using S-adenosyl-l-methionine (AdoMet) as the cosubstrate. Synthetic AdoMet analogues are powerful tools to site-specifically introduce a variety of functional groups and exhibit potential to be converted only by distinct MTases. Extending the size of the substituent at the sulfur/selenium atom provides selectivity among MTases but is insufficient to discriminate between promiscuous MTases. We present a panel of AdoMet analogues differing in the nucleoside moiety (NM-AdoMets). These NM-AdoMets were efficiently produced by a previously uncharacterized methionine adenosyltransferase (MAT) from methionine and ATP analogues, such as ITP and N6-propargyl-ATP. The N6-modification changed the relative activity of three representative MTases up to 13-fold resulting in discrimination of substrates for the methyl transfer and could also be combined with transfer of allyl and propargyl groups.
Keyphrases
  • molecular docking
  • structure activity relationship
  • photodynamic therapy
  • molecular dynamics
  • cross sectional
  • cancer therapy
  • risk assessment
  • drug delivery
  • climate change
  • light emitting